Seeing Is Believing
Currently, out of the existing stock ratings of David Low - 10 which are a Hold (62.5%), 6 which are a Buy (37.5%)
Analyst David Low works at JPMORGAN and is covering the Healthcare sector with 27 price targets and ratings displayed on 1 stocks. Previously, David Low worked at DEUTSCHE BANK.
David Low's average stock forecast success ratio is 72.73% with an average time for price targets to be met of 244 days.
Most recent stock forecast was given on RMD, ResMed at 27-Jan-2023.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $19.45 (9.75%) receiving and performance score of 4.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
230
$82.13 (55.54%)
250
12 days ago
4/7 (57.14%)
$20.28 (13.21%)
75
Buy
180
$32.13 (21.73%)
255
17 days ago
9/11 (81.82%)
$3.07 (1.42%)
53
Hold
180
$32.13 (21.73%)
24 days ago
5/6 (83.33%)
$23.96 (22.96%)
431
Buy
260
$112.13 (75.83%)
280
1 months 26 days ago
0/5 (0%)
$61.17 (29.12%)
Buy
245
8 months 3 days ago
8/11 (72.73%)
$7.58 (7.73%)
244
What Year was the first public recommendation made by David Low?